Last reviewed 2026-04-23 · How we verify

hMG-IBSA

Human menopausal gonadotropin is used to stimulate ovulation in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders.

Human menopausal gonadotropin is used to stimulate ovulation in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders. Used for Induction of ovulation in anovulatory infertile women.

At a glance

Mechanism of action

hMG-IBSA works by stimulating the ovaries to produce eggs, which can then be fertilized. This is achieved through the administration of human menopausal gonadotropin, a hormone that mimics the action of luteinizing hormone and follicle-stimulating hormone. By stimulating ovulation, hMG-IBSA can help women with PCOS or other ovulatory disorders to conceive.

Approved indications

• Induction of ovulation in anovulatory infertile women

Common side effects

• Ovarian hyperstimulation syndrome

Key clinical trials

• The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles (PHASE4)
• The Difference Between POSEIDON Group 3 and Group 4 as Regards IVF
• Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate Resistance (PHASE2, PHASE3)
• The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome (NA)
• Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle
• Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders (PHASE4)
• Efficacy Study Comparing the Effect of Clomiphencitrate to an Antagonist Protocol (PHASE4)
• Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.